Results 31 to 40 of about 4,768 (212)
Diagnosis and treatment of icteric hepatitis caused by erythropoietic protoporphyria: A case report
Erythropoietic protoporphyria (EPP) is a rare inherited disease caused by partial deficiency activity of the enzyme ferrochelatase (FECH), resulting in excessive accumulation of protoporphyrin IX in erythrocyte and tissues. Here, we report a patient with
Hanqing Huang +3 more
doaj +1 more source
Ferrochelatase of spinach chloroplasts [PDF]
Spinach chloroplasts catalyse the incorporation of Fe2+ into protoporphyrin, mesoporphyrin and deuteroporphyrin to form the corresponding haems. This ferrochelatase activity was detected by pyridine haemochrome formation with acetone-dried powders of chloroplasts, or from the formation of [59Fe]haems by intact chloroplasts. Decreasing the mitochondrial
openaire +2 more sources
Substrate interactions with human ferrochelatase [PDF]
Ferrochelatase, the terminal enzyme in heme biosynthesis, catalyzes the insertion of ferrous iron into protoporphyrin IX to form protoheme IX. Human ferrochelatase is a homodimeric, inner mitochondrial membrane-associated enzyme that possesses an essential [2Fe-2S] cluster.
Amy, Medlock +4 more
openaire +2 more sources
Hyperlipidemia and atherosclerosis associated with liver disease in ferrochelatase-deficient mice1
Erythropoietic protoporphyria (EPP) is an inherited disorder of heme synthesis caused by deficiency of the mitochondrial enzyme ferrochelatase. EPP in humans is associated with liver disease, hypertriglyceridemia, and a low level of high density ...
Vincent W. Bloks +9 more
doaj +1 more source
Inhibition of ferrochelatase impairs vascular eNOS/NO and sGC/cGMP signaling. [PDF]
Ferrochelatase (FECH) is an enzyme necessary for heme synthesis, which is essential for maintaining normal functions of endothelial nitric oxide synthase (eNOS) and soluble guanylyl cyclase (sGC). We tested the hypothesis that inhibition of vascular FECH
Bin Zhang +6 more
doaj +1 more source
Alectinib treatment improves photodynamic therapy in cancer cell lines of different origin
Background Photodynamic therapy with a photosensitizer such as protoporphyrin-IX, a light sensitive metabolite of heme synthesis, is a highly selective treatment for various carcinomas.
Bernhard Gillissen +3 more
doaj +1 more source
Erythropoietin signaling regulates heme biosynthesis
Heme is required for survival of all cells, and in most eukaryotes, is produced through a series of eight enzymatic reactions. Although heme production is critical for many cellular processes, how it is coupled to cellular differentiation is unknown ...
Jacky Chung +21 more
doaj +1 more source
Crosstalk between metal ions in Bacillus subtilis ferrochelatase
Ferrochelatase (EC 4.99.1.1), the terminal enzyme in the heme biosynthetic pathway, catalyzes the insertion of Fe2+ into protoporphyrin IX, generating heme.
Hansson, Mattias +2 more
core +2 more sources
Cloning of murine ferrochelatase. [PDF]
Ferrochelatase (protoheme ferro-lyase, EC 4.99.1.1) catalyzes the last step in the heme biosynthetic pathway, the chelation of ferrous iron and protoporphyrin to form heme. The activity of ferrochelatase is deficient in the inherited disease protoporphyria.
D A, Brenner, F, Frasier
openaire +2 more sources
Direct Spectroscopic Ferrochelatase Assay. [PDF]
Ferrochelatases (E.C. 4.99.1.1) catalyze the insertion of ferrous iron into either protoporphyrin IX to make protoheme IX or coproporphyrin III to make coproheme III. Ferrochelatase activity in extracts or purified protein can be measured via several assays.
Dailey HA, Medlock AE.
europepmc +3 more sources

